In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.

Détails

ID Serval
serval:BIB_1BCA842865A6
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.
Périodique
Antimicrobial Agents and Chemotherapy
Auteur(s)
Mancini S., Laurent F., Veloso T.R., Giddey M., Vouillamoz J., Vandenesch F., Moreillon P., Entenza J.M.
ISSN
1098-6596 (Electronic)
ISSN-L
0066-4804
Statut éditorial
Publié
Date de publication
2015
Volume
59
Numéro
4
Pages
2435-2438
Langue
anglais
Résumé
Methicillin-resistant Staphylococcus aureus (MRSA) carrying the mecC gene (mecC-MRSA) exhibited at 37°C MICs of oxacillin close to those of methicillin-susceptible S. aureus (MSSA). We investigated whether at this temperature, mecC-MRSA strains respond to flucloxacillin treatment like MSSA strains, using a rat model of endocarditis. Flucloxacillin (human-like kinetics of 2 g intravenously every 6 h) cured 80 to 100% of aortic vegetations infected with five different mecC-MRSA strains. These results suggest that mecC-MRSA infections may successfully respond to treatment with β-lactams.
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/02/2015 15:25
Dernière modification de la notice
20/08/2019 13:52
Données d'usage